Zymergen Files Liquidation Plan As Ch. 11 Case Begins In Del.
Biotechnology company Zymergen Inc. filed a plan of liquidation Wednesday describing proposed treatment of creditor classes as the company kicked off its Chapter 11 case with a first-day hearing in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article